ࡱ> ehfG abjbjَ *u3]pppp444HHHH8 H+~zzz+++++++$X-L/T+4z|zz+6ppF666zvp8R+HHppppz+6Z 6("+ •t-HHF;+d 14 October 2008 Mr Sean Dougherty Therapeutic Group Manager PHARMAC P.O. Box 10 254 Wellington 6143 PHARMAC proposal to subsidise an additional brand of levothyroxine Dear Mr Dougherty With the proposal to list another brand of levothyroxine in the Pharmaceutical Schedule would consideration be given to the addition of smaller strengths of tablets to accommodate paediatric dosing. The suppliers of both Eltroxin and Goldshield levothyroxine have indicated the tablets should not be halved; however from a pharmaceutical perspective we need to compound an oral liquid from the 50 or 100 microgram tablets to formulate a 15 microgram per ml strength. Our request is for the addition of a 25 microgram tablet and, ideally a 12.5 microgram tablet to enable daily or alternate daily dosing. Yours sincerely Brenda Hughes Convenor Pharmacists Special Interest Group THE PAEDIATRIC SOCIETY OF NEW ZEALAND Secretariat: Email:Denise Tringham P O Box 22 234 Wellington 6441 Tel: (04) 938 4827 Fax: (04) 976 4827 psnz@paradise.net.nz  Health of our children: Wealth of our nation 7psuvw!"#%(a jUmH5B*CJOJQJB*CJOJQJ5B*CJ(OJQJ5B*CJ$OJQJ 5OJQJj5OJQJUmH5CJCJ,FN_op$%5678tuw "#$%)-./^a    8FGPstuw "$ $  $ !Sn# $ !Sn# $x$ $ "#$%)*+,-./^_`a$ ! $ !n# ! $$ u+#(&P . A!"#$%n [L@LNormal$*$d @CJOJQJmH 00 Heading 1$@&500 Heading 2$@&>* Heading 3m$$*$@& \R" b2> Y!r"B%(*-0R3"68;>bA2DGI56@CJ00 Heading 4$@&CJ44 Heading 5$@&5CJ44 Heading 6$@&5CJ88 Heading 7 $$@&5CJ44 Heading 8 $$@&5<A@<Default Paragraph Font<<Address$5OJQJhmH nH 0@0Header  !CJ0 0Footer  !CJ(U@!( Hyperlink>*B*8V@18FollowedHyperlink>*B* LB@BL Body Text$*$1$ p@ @hnH F>RFTitle$*$1$ p@ 5CJ0hnH .Pb. Body Text 2CJXCrXBody Text Indent$*$ 0@CJ2Q2 Body Text 3$CJ W@ Strong544 No Spacing CJmH nH a2a25aa8"a a t  ,R$@yV7e\]{W- @&  ( =z43 N CE%"  8   BCqDELFVSS?-;lbn2qk\D@ORQ8Q* gw  W <b14\5q<O>B 1 8w1N/ : f 1  y?  u M  4  `6U:LsNA_cknkAehS)8Z' sZ' *b?@`CE%"   TB CnDExFf%Ip,0A  K *   8 h  L  D kk nPn&k X>>@@`4B "H2   #  #$H2   # | N  3  N  3  TB  c $DjJ 0( ? B S  ?a=^tuD$t#u"+u*+-bSZu*+-bDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Council\Wellington Meetings with Minister of Health etc\Coverig Letter to Margie Apa.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Council\Wellington Meetings with Minister of Health etc\Coverig Letter to Margie Apa.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Council\Wellington Meetings with Minister of Health etc\Margie Apa Mtg\Covering Letter to Margie Apa.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Managed Clinical Networks and Tertiary Services\2008 Proposals\Proposal Aug 08\Ltr to Margie Apa 18 August 08.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Managed Clinical Networks and Tertiary Services\2008 Proposals\Proposal Aug 08\Ltr to Margie Apa 18 August 08.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Managed Clinical Networks and Tertiary Services\2008 Proposals\Proposal Aug 08\Ltr to Margie Apa 18 August 08.docDeniselC:\Documents and Settings\Denise\WORK\PSNZ Docs\Letterheads and Logos\Letterheads\Secretariat Letterhead.docDeniselC:\Documents and Settings\Denise\WORK\PSNZ Docs\Letterheads and Logos\Letterheads\Secretariat Letterhead.docDeniselC:\Documents and Settings\Denise\WORK\PSNZ Docs\Letterheads and Logos\Letterheads\Secretariat Letterhead.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Submissions and Position Statements\2008\Phamary SIG's Comments Re Levothyroxine Oct 08.doc!|} D~NsrtZ*PpTVxGzfm "W 1 Kx=FP v  {n -  :. CB|0 B1 J3ѪnV 3 `l9 -J &X T] qc  r\4 t :u [ .... OJQJo( OJQJo( OJQJo( OJQJo(hh. hhOJQJo(^`.^`OJQJ- hh^h`OJQJo(0^`0o(. hhOJQJo(^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.hho(. hhOJQJo( hhOJQJo( hh^h`OJQJo(hh.hh.0^`0o(.?o(.hh>*o(.?o(. hhOJQJo( hhOJQJo( hhOJQJo(?o(.hho(. hhOJQJo( hhOJQJo(!&XP rV 3B1CB|0~}| :.mJ3"[T]qc-J 1{n -v :uKx= tl9!WW8Num1WW8Num2@ss8Wssa`@GzTimes New Roman5Symbol3& zArial?Bodoni BookEAGaramond BoldA& Arial Narrow"qhmrFmrFC†#20 TAX INVOICEracpDeniseOh+'0p   , 8 DPX`h TAX INVOICEAX racpNVOacp Normal.dotDenised2niMicrosoft Word 8.0@F#@2s@Ft-@Ft-՜.+,D՜.+,< hp  racpO   TAX INVOICE Title 6> _PID_GUIDAN{792604B6-65F6-47F3-82ED-7C0FC3A40D78}  !"#$&'()*+,./012347Root Entry F@ڈt-ҕt-91Table /WordDocument*SummaryInformation(%DocumentSummaryInformation8-CompObjj  FMicrosoft Word Document MSWordDocWord.Document.89qOh+'0p   , 8 DPX`h TAX INVOICEAX racpNVOacp Normal.dotDenised3niMicrosoft Word 8.0@Ik@2s@Ft-@t-՜.+,D՜.+,< hp  racpO   TAX INVOICE Title 6> _PID_GUIDAN{792604B6-65F6-47F3-82ED-7C0FC3A40D78}7psuvw!"#%(aZ\lnp D! jUmH5B*CJOJQJB*CJOJQJ5B*CJ(OJQJ5B*CJ$OJQJ 5OJQJj5OJQJUmH5CJCJ((&P . A!"#$%n 14 October 2008 Mr Sean Dougherty Therapeutic Group Manager PHARMAC P.O. Box 10 254 Wellington 6143 e-mail - sean.dougherty@pharmac.govt.nz PHARMAC Proposal to Subsidise an Additional Brand of Levothyroxine Dear Mr Dougherty, With the proposal to list another brand of levothyroxine in the Pharmaceutical Schedule would consideration be given to the addition of smaller strengths of tablets to accommodate paediatric dosing. The suppliers of both Eltroxin and Goldshield levothyroxine have indicated the tablets should not be halved; however from a pharmaceutical perspective we need to compound an oral liquid from the 50 or 100 microgram tablets to formulate a 15 microgram per ml strength. Our request is for the addition of a 25-microgram tablet and, ideally a 12.5 microgram tablet to enable daily or alternate daily dosing. Yours sincerely Brenda Hughes Convenor Pharmacists Special Interest Group THE PAEDIATRIC SOCIETY OF NEW ZEALAND Secretariat: Email:Denise Tringham P O Box 22 234 Wellington 6441 Tel: (04) 938 4827 Fax: (04) 976 4827 psnz@paradise.net.nz   Health of our children: Wealth of our nation ^ Z\  "hjlp$ p , L t  $ !n# ! $$ u+#$ $  $ !Sn# $ !Sn#$  $x$  >!@!B!D!$ ! ! (&P . A!"#$%n"#$%)*+,-./^_`a,.02468:Z\^$ ! $ !n# ! $$ u+# [L`LNormal$*$d @CJOJQJmH 00 Heading 1$@&500 Heading 2$@&>* Heading 3m$$*$@& \R" b2> Y!r"B%(*-0R3"68;>bA2DGI56@CJ00 Heading 4$@&CJ44 Heading 5$@&5CJ44 Heading 6$@&5CJ88 Heading 7 $$@&5CJ44 Heading 8 $$@&5<A@<Default Paragraph Font<<Address$5OJQJhmH nH 0@0Header  !CJ0 0Footer  !CJ(U@!( Hyperlink>*B*8V@18FollowedHyperlink>*B* LBBL Body Text$*$1$ p@ @hnH F>RFTitle$*$1$ p@ 5CJ0hnH .Pb. Body Text 2CJXCrXBody Text Indent$*$ 0@CJ2Q2 Body Text 3$CJ W@ Strong544 No Spacing CJmH nH 225(,FN_opOPQRbcdes|%9NOPQUWYZ[@@@@@@@@@@@@@@@@@@@ D!8"^p D! a UnknownDeniseThe Walker Familyt  ,R$@yV7e\]{W- @&  ( =z43 N CE%"  8   BCqDELFVSS?-;lbn2qk\D@ORQ8Q* gw  W <b14\5q<O>B 1 8w1N/ : f 1  y?  u M  4  `6U:LsNA_cknkAehS)8Z' sZ' *b?@`CE%"   TB CnDExFf%Ip,0A  K *   8 h  L  D kk nPn&k X>>@@`4B "H2   #  #$H2   # | N  3  N  3  TB  c $DjJ 0( ? B S  ?=^tuD$t#uVWYSZpvPQVWYDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Council\Wellington Meetings with Minister of Health etc\Coverig Letter to Margie Apa.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Council\Wellington Meetings with Minister of Health etc\Margie Apa Mtg\Covering Letter to Margie Apa.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Managed Clinical Networks and Tertiary Services\2008 Proposals\Proposal Aug 08\Ltr to Margie Apa 18 August 08.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Managed Clinical Networks and Tertiary Services\2008 Proposals\Proposal Aug 08\Ltr to Margie Apa 18 August 08.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Managed Clinical Networks and Tertiary Services\2008 Proposals\Proposal Aug 08\Ltr to Margie Apa 18 August 08.docDeniselC:\Documents and Settings\Denise\WORK\PSNZ Docs\Letterheads and Logos\Letterheads\Secretariat Letterhead.docDeniselC:\Documents and Settings\Denise\WORK\PSNZ Docs\Letterheads and Logos\Letterheads\Secretariat Letterhead.docDeniselC:\Documents and Settings\Denise\WORK\PSNZ Docs\Letterheads and Logos\Letterheads\Secretariat Letterhead.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Submissions and Position Statements\2008\Phamary SIG's Comments Re Levothyroxine Oct 08.docDeniseC:\Documents and Settings\Denise\WORK\PSNZ Docs\Submissions and Position Statements\2008\Phamary SIG's Comments Re Levothyroxine Oct 08.doc!|} D~NsrtZ*PpTVxGzfm "W 1 Kx=FP v  {n -  :. CB|0 B1 J3ѪnV 3 `l9 -J &X T] qc  r\4 t :u [ .... OJQJo( OJQJo( OJQJo( OJQJo(hh. hhOJQJo(^`.^`OJQJ- hh^h`OJQJo(0^`0o(. hhOJQJo(^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.hho(. hhOJQJo( hhOJQJo( hh^h`OJQJo(hh.hh.0^`0o(.?o(.hh>*o(.?o(. hhOJQJo( hhOJQJo( hhOJQJo(?o(.hho(. hhOJQJo( hhOJQJo(!&XP rV 3B1CB|0~}| :.mJ3"[T]qc-J 1{n -v :uKx= tl9!WW8Num1WW8Num2@PP8WPNt,8npxyNPber| QVWXY`*`,`.`0`2`4a``a aa`X`Zalanaaaaaaa`aa`a a``aaa```a``"`h`j`la@ `J ` ` ` ` ` `@!`B!GzTimes New Roman5Symbol3& zArial?Bodoni BookEAGaramond BoldA& Arial Narrow"hmrFprFC†#24 TAX INVOICEracpDeniseG abjbjَ *(3]ppp444H 8 4H3~ HHH+1-1-1-1-1-1-1$H5<7TQ1y4H|HHQ1pp F: HH"p8 R +1HHppppH+1` !/."+1 . gu-Hn jR0dRoot Entry F@ڈt-gu-j@1Table /WordDocumentc*(SummaryInformation( < F !"#$>?@ABCDE=HIJKLMNOPQRSTUVWXYZ[\]^_`abdgkiDocumentSummaryInformation8CompObjj0TableG7 {792604B6-65F6-47F3-82ED-7C0FC3A40D78}Oh+'0p   , 8 DPX`h TAX INVOICEAX racpNVOacp Normal.dotDenised3niMicrosoft Word 8.0@Ik@2s@Ft-@t-  FMicrosoft Word Document MSWordDocWord.Document.89q՜.+,D՜.+,< hp  racpO   TAX INVOICE Title 6> _PID_GUIDAN Paediatric Society of New Zealand: Submissions
Skip to main content

Submissions

The Paediatric Society believes all children and youth should, by right, attain optimal physical, mental and social health and wellbeing.  By working as a coordinated national network of health professionals the Society dedicates its efforts and resources to making official submissions to both Government and Non-Government organisations on issues that will impact on the health and wellbeing of children and young people.

Sorry, the requested view was not found.

The technical reason is: No template was found. View could not be resolved for action "download" in class "Ocular\Filemanager\Controller\FileController".